跳至主要内容
临床试验/EUCTR2004-003479-35-AT
EUCTR2004-003479-35-AT进行中(未招募)不适用

PHARMACOKINETICS OF VORICONAZOLE DURING CONTINUOUS VENOVENOUS HEMODIAFILTRATION - Voriconazole during CVVHDF

Internal Medicine IV, Mecdical University of Vienna0 个研究点目标入组 7 人开始时间: 2005年11月28日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
7

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age < 18 years
  • suspected or proven fungal infection requiring parenteral antifungal therapy with voriconazole
  • continuous venovenous hemodiafiltration due to acute renal failure
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • requirement of another extracorporal therapy rather than CVVHDF
  • hypersensitivity or other intolerance to voriconazole
  • patients receiving terfenadine, astemizole, cisapride, primozide, quinidine, sirolimus, rifampin, rifabutin, efavirenz, carbamazepine, long-acting barbiturates, ritonavir, phenytoin, ergot alkaloids
  • women of childbearing potential

研究者

发起方
Internal Medicine IV, Mecdical University of Vienna

相似试验